EPAS1 and kidney cancer: Evaluation of this action of HIF is important given efforts to treat VHL-defective kidney cancer through HIF2A–HIF1B dimerization inhibitors11,12, whose action to prevent transcription might be circumvented by effects of HIF2A on translation.